Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8386346rdf:typepubmed:Citationlld:pubmed
pubmed-article:8386346lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:8386346lifeskim:mentionsumls-concept:C0004112lld:lifeskim
pubmed-article:8386346lifeskim:mentionsumls-concept:C0001455lld:lifeskim
pubmed-article:8386346lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:8386346lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:8386346lifeskim:mentionsumls-concept:C0220839lld:lifeskim
pubmed-article:8386346lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:8386346lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:8386346lifeskim:mentionsumls-concept:C1157645lld:lifeskim
pubmed-article:8386346lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:8386346pubmed:issue2lld:pubmed
pubmed-article:8386346pubmed:dateCreated1993-5-17lld:pubmed
pubmed-article:8386346pubmed:abstractTextWe examined the effects of glutamate receptor agonists on cyclic AMP (cAMP) formation in cultured astrocytes. L-Glutamate reduced the cAMP formation induced by either isoproterenol (IC50 7 microM) or forskolin without affecting the basal level. Glutamate agonists reduced the cAMP formation in astrocytes with the following rank order of potency: L-glutamate > trans-(+/-)-1-aminocyclopentane-1,3-dicarboxylic acid (t-ACPD) = quisqualate. Pretreatment of astrocytes with pertussis toxin resulted in a partial reduction of the glutamate response and a complete attenuation of the t-ACPD response. These results suggest that astrocytes have another type of metabotropic glutamate receptor which inhibits adenylate cyclase through pertussis toxin-sensitive G-proteins.lld:pubmed
pubmed-article:8386346pubmed:languageenglld:pubmed
pubmed-article:8386346pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:citationSubsetIMlld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386346pubmed:statusMEDLINElld:pubmed
pubmed-article:8386346pubmed:monthJanlld:pubmed
pubmed-article:8386346pubmed:issn0304-3940lld:pubmed
pubmed-article:8386346pubmed:authorpubmed-author:HashimotoHHlld:pubmed
pubmed-article:8386346pubmed:authorpubmed-author:BabaAAlld:pubmed
pubmed-article:8386346pubmed:authorpubmed-author:SageLLlld:pubmed
pubmed-article:8386346pubmed:issnTypePrintlld:pubmed
pubmed-article:8386346pubmed:day12lld:pubmed
pubmed-article:8386346pubmed:volume149lld:pubmed
pubmed-article:8386346pubmed:ownerNLMlld:pubmed
pubmed-article:8386346pubmed:authorsCompleteYlld:pubmed
pubmed-article:8386346pubmed:pagination182-4lld:pubmed
pubmed-article:8386346pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:meshHeadingpubmed-meshheading:8386346-...lld:pubmed
pubmed-article:8386346pubmed:year1993lld:pubmed
pubmed-article:8386346pubmed:articleTitleInhibitory glutamate response on cyclic AMP formation in cultured astrocytes.lld:pubmed
pubmed-article:8386346pubmed:affiliationDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Osaka University, Japan.lld:pubmed
pubmed-article:8386346pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8386346pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8386346lld:pubmed